Centre Hospitalier Public Du Cotentin — Clinical Trial Site

16 Registered trials

7 Currently recruiting

Organisation

Centre Hospitalier Public Du Cotentin

Location

Cherbourg-En-Cotentin, France

Identifier

ORG-100046300

Address

46 Rue Val De Saire, 50100, France

Departments

Anesthésie-réanimation
Cardiologie
Cardiology
CH Public du Cotentin
Intensive care
Médecine interne
Néphrologie
Néphrologie-Hémodialyse
Oncologie
Oncology
Pneumologie
Réanimation
Service Rhumatologie

Clinical trials at this site (16)

Search interface

SPironolactONe for the maintenance of Sinus Rhythm in hypertensive patients with atrial fibrillation and preserved left ventricular ejection… Pending

2024-518146-25-00 patients with atrial fibrillation and preserved left ve 5
Comparison of Landiolol versus standard of care for prevention of mortality in patients hospitalized for a septic shock with hypercontractli… Pending

2024-518251-31-00 patients hospitalized for a septic shock with hypercont 5
RANDOMIZED, CONTROLLED, OPEN TRIAL OF TWO STANDARDIZED DECLINE SCHEMES, FAST (NORTH AMERICAN) AND SLOW (EUROPEAN) RESPECTIVELY, OF CORTISONE… Pending

2024-518653-41-00 Patients with giant cell arteritis (= Horton’s disease) 5
Safety and efficacy of very short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy in older patients undergoing percutaneou… Recruiting

2023-507545-28-00 Elderly patients ≥ 65 years successfully treated with p 6 2026-03-06
Prophylactic Anti-aRrhythmic therapy with Amiodarone in critically ill patients admitted for an out-of-hospital Cardiac Arrest with initial … Recruiting

2023-510099-30-00 Out-of-hospital cardiac arrest with initial shockable r 5 2025-09-23
Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non valvular atrial fibrillation: a randomized controll… Recruiting

2023-507544-37-00 patients with end-stage renal disease on chronic perito 5 2025-01-08
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 colon carcinoma 5 2024-08-14
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-07-04
A multicenter randomized trial to evaluate the efficacy of pioglitazone to improve renal outcome in ANCA-associated vasculitis - RENATO Recruiting

2022-501057-36-00 ANCA-associated vasculitis 5 2023-10-24
Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for… Recruiting

2024-511904-18-00 Pancreatic adenocarcinoma (PAC) 10 2020-07-08
DAPAgliflozine to attenuate cardiac RemOdeling afTEr aCuTe myOcardial infarction Ended

2024-511882-13-01 Cardiac failure 5 2024-11-19
Hydrocorticose and vasopressin in post-resuscitation syndrome Ended

2024-516373-77-00 Adult cardiac arrest patients with sustained ROSC and h 5 2021-07-18
PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient… Ended

2024-518741-21-00 colon cancer 4 2014-12-23
Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free … Ended

2024-516198-61-00 Patients with high risk of relapse, ER+ and HER2- prima 5 2013-06-05
Non-inferiority study of a new therapeutic strategy for gout: immediate prescription of a hypouricemia treatment, febuxostat, compared to it… Halted

2024-515547-34-00 The gout 5 2025-08-12
Does high-dose vitamin B3 supplementation prevent major adverse kidney events during septic shock? A multicenter randomized controlled study Ended

2024-517055-13-00 adverse kidney events during septic shock 5